IPOs 2022

A list of Biotech IPOs in 2022, their targets, platforms, indications and lead-candidate stage.

IPOs 2021

A list of Biotech IPOs in 2021, their targets, platforms, indications and lead-candidate stage.

MCL-1

Drug development landscape in targeting MCL-1.

PRMT5

Drug development landscape in targeting PRMT5.

RAS, SOS1, SHP2

Drug development landscape in targeting RAS, SOS1 and SHP2 within the mitogenic pathway.

SCD

Drug development landscape in the treatment of sickle cell disease.

SMA

Drug development landscape in the treatment of spinal muscular atrophy.

wAMD

Drug development landscape in the treatment of wet age-related macular degeneration.

SUBSCRIBE